Olema Pharmaceuticals inc (OLMA)
10.87
+0.01
(+0.09%)
USD |
NASDAQ |
Apr 15, 16:00
10.85
-0.02
(-0.18%)
After-Hours: 20:00
Olema Pharmaceuticals Net Income (Quarterly): -26.77M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -26.77M |
| September 30, 2023 | -21.50M |
| June 30, 2023 | -20.10M |
| March 31, 2023 | -28.29M |
| December 31, 2022 | -26.18M |
| September 30, 2022 | -22.72M |
| June 30, 2022 | -32.86M |
| March 31, 2022 | -23.03M |
| December 31, 2021 | -21.64M |
| Date | Value |
|---|---|
| September 30, 2021 | -17.71M |
| June 30, 2021 | -16.41M |
| March 31, 2021 | -15.34M |
| December 31, 2020 | -10.13M |
| September 30, 2020 | -7.844M |
| June 30, 2020 | -2.453M |
| March 31, 2020 | -1.693M |
| December 31, 2019 | -1.017M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-32.86M
Minimum
Jun 2022
-1.017M
Maximum
Dec 2019
-17.39M
Average
-20.10M
Median
Jun 2023
Net Income (Quarterly) Benchmarks
| Geron Corp | -51.97M |
| Verastem Inc | -27.37M |
| Fate Therapeutics Inc | -44.12M |
| Karyopharm Therapeutics Inc | -41.84M |
| Alpine Immune Sciences Inc | 5.96M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 30.42M |
| EPS Diluted (Quarterly) | -0.48 |
| Enterprise Value | 345.99M |
| Earnings Yield | -19.78% |